Opportunity
SAM #W519TC-25-R-0041
Award for IMX-104 Insensitive Munition Explosive Production Facility Design and Build
Buyer
W6QK ACC-RI
Posted
September 09, 2026
Identifier
W519TC-25-R-0041
NAICS
237990, 332993, 325920
This award notice announces a major contract for the U.S. Army to establish new production capability for insensitive munition explosives. - Government Buyer: - U.S. Army Portfolio Acquisition Executive Agile Sustainment & Ammunition (PAE) - U.S. Army Contracting Command – Rock Island (ACC-RI) - OEM/Vendor: - Nitradyn, LLC (sole-source awardee) - Products/Services Requested: - Turnkey design, construction, and commissioning of an IMX-104 insensitive munition explosive production facility - Facility to be located in Graham, Kentucky - Notable Requirements: - Sole-source contract awarded under special statutory authorities and Army acquisition regulations - Full establishment of IMX-104 production capability - Contract value up to $581,160,062 - Nitradyn, LLC is the only OEM/vendor mentioned - Technical Context: - IMX-104 is a specific insensitive munition explosive, designed for improved safety and performance - The contract covers all necessary design and build services for the facility
Description
On September 09, 2026 the U.S. Army’s Portfolio Acquisition Executive Agile Sustainment & Ammunition (PAE) and U.S. Army Contracting Command – Rock Island awarded an undefinitized contract action with a not-to-exceed amount of $581,160,062.00 to Nitradyn, LLC to design, build, and commission an IMX-104 production facility in Graham, Kentucky. The contract was executed as a sole-source action under the authorities of Section 3204(a)(7) of Title 10, United States Code (10 U.S.C. 3204(a)(7)), Subsection 1244(a)(2), of the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023, as amended by Section 1242 of the NDAA for Fiscal Year 2024, Defense Pricing, Contracting, and Acquisition Policy (DPCAP) Class Deviation 2024-O0005, Army Federal Acquisition Regulation Supplement (AFARS) 5106.103-790 and Appendix GG.